Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 2 Blood.

Slides:



Advertisements
Similar presentations
Chapter 19 Hematologic Products.
Advertisements

Drugs for Coagulation Disorders
Drugs for Coagulation Disorders Andrew N. Schmelz, PharmD Post-Doctoral Teaching Fellow Purdue University October 8, 2008
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
ANAESTHESIA AND ANTICOAGULANTS
Thromboembolic Disorders and Related Medications Nsg 106 Pharmacotherapeutics.
Vascular Pharmacology
PTP 546 Module 6 Cardiovascular Pharmacology: Part II Jayne Hansche Lobert, MS, RN, ACNS-BC, NP 1Lobert.
Coagulation Modifier Drugs
Blood S-J Tsai Department of Physiology. Composition Composed of cells (erythrocytes, leukocytes, and platelets) and plasma (the liquid in which the cells.
Week 7: Fibrinolysis and Thrombophilia Secondary fibrinolysis Secondary fibrinolysis Primary fibrinolysis Primary fibrinolysis Plasminogen Plasminogen.
Anticoagulation in the Acute Care Population Aimee Ring PT, DPT, GCS.
Principles of anticoagulant tratment
FUNCTIONS OF THE COAGULATION SYSTEM ACTIONDESIRED RESULT Rapid formation of mechanically sound clot Stop bleeding quickly Prevent clot formation at non-injured.
Clot Lysis and Intravascular Anticoagulants
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Coagulation Modifier Drugs.
Agents Affecting Blood Clotting. Anticoagulant Agents Prevent the extension and formation of clots. Inhibition by interference with the ‘coagulation cascade’
Anticoagulant, Fibrinolytic and Antiplatelet
HMIM BLOCK 224 PLATELET AND HEMOSTASIS Dr. Zahoor Lecture - 6.
ANTICOAGULANT BY :DR ISRAA OMAR.
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
Drugs used in coagulation disorders By S.Bohlooli, Ph.D.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
ANTICOAGULANT, THROMBOLYTICS & ANTIPLATELET DRUGS.
Study Guide Guide for Patients Undergoing Anticoagulant Therapy.
Chapter 22 Agents Used to Treat Anemias. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Anemia.
Antiplatelet Drugs - Principles Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.
Review of Anticoagulants, Thrombolytics and Anti-platelet Drugs 4 October :06 PM.
Drugs for Coagulation disorders. There are a number of different categories of drugs which modify the coagulation process: I. Anticoagulants II. Antiplatelet.
Thrombolytic drugs BY :DR. ISRAA OMAR.
BY :DR. ISRAA OMAR.  It is initiated concomitantly with coagulation cascade, resulting in the formation of active plasmin,which digest fibrin.  The.
Developed by: Dawn Johnson, RN, MSN, Ed.  Internally and externally  Prevent bleeding from wounds which could lead to shock or even death.
Anticoagulations and Coagulants
Drugs Used to Treat Thromboembolic Disorders Chapter 27 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Fibrinolytics, anticoagulants and antiplatelets
THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar.
Antiplatelet drugs Dr.V.V.Gouripur. Antiplatelet drug An antiplatelet drug is a member of a class of drugs that decreases platelet aggregation and inhibits.
Chapter 9 Medications that Affect Coagulation Elsevier items and derived items © 2006 by Saunders, an imprint of Elsevier Inc.
Blood coagulation is a complex process that involves vasoconstriction, platelet clumping or aggregation, and a cascade of clotting factors produced in.
THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar
Anticoagulants, Thrombolytic Agents and Antiplatelet Drugs
Agents Affecting Blood Clotting
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
Physiology of Blood. Platelets Small granulated non-nucleated bodies 2-4 micron in diameter Life span….. 8 days Count…300,000/mm 3.
Chapter 19 Agents affecting Blood Clotting. Blood Clotting p461 Clotting is necessary to prevent fatal loss of blood from a minor injury Thromboemboli.
Prof. Yieldez Bassiouni
Anticoagulants, Antiplatelets, and Thrombolytics
Anticoagulants Course: Pharmacology I Course Code: PHR 213 Course Instructor: Sabiha Chowdhury Lecturer Department of Pharmacy BRAC University.
Drugs Used in Coagulation Disorders
Anticoagulant, Antiplatelet, and Thrombolytic Drugs.
II. Antiplatelet Drugs.
23 Anticoagulants.
Drugs affecting coagulation and dental management
Secondary Haemostasis
Blood/Blood Formation
Anticoagulants, Antiplatelets, and Thrombolytics
These factors prevent blood clotting - in normal state.
Streptokinase (DB00086) Approved Drug
Drugs Used in Coagulation Disorders
Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College
Coagulation Modifier Drugs
داروهای موثر بر سیستم قلبی وعروقی جدید در ایران
Coagulation Disorders
ANTICOAGULANTS Dr. A. Shyam Sundar. M.Pharm., Ph.D,
23 Anticoagulants.
Drugs Affecting Blood.
Anticoagulants.
Antiplatelet Drugs Dr. : Asmaa Fady MD., MSC, M.B, B.Ch
Presentation transcript:

Chapter 19 Agents Affecting Blood Clotting

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Blood Clotting Thromboemboli  Cause many deaths per year Anticoagulants  Prevent the formation of coagulants

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Anticoagulant Agents Inhibit the formation of clots  Heparin  Found in mast cells  Action  Inhibit the clotting process

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Heparin Heparin action  Indirectly interferes with the conversion of prothrombin to thrombin  The deficiency of thrombin prevents the conversion of fibrinogen to fibrin (continues)

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Heparin Destroyed if given orally Administered via IV infusion  No intramuscular injections Administered subcutaneously  Longer acting form  No intramuscular injections (continued)

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Heparin: Side Effects Hemorrhage Allergy Antidote  Protamine sulfate Caution  Do not administer to clients with coagulation disorders

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Low Molecular Weight Anticoagulant Related to heparin  Minor risk for bleeding Does not affect the action of thrombin in the clotting cascade (continues)

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Low Molecular Weight Anticoagulant Example: enoxaparim (Lovenox) (continued)

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Oral Anticoagulants Warfarin (Coumadin)  Inhibits blood clotting by interfering with the synthesis of vitamin K-dependent clotting factors Close client monitoring  Dosage is individualized  International normalized ratio

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Antiplatelet Agents Action: inhibit the aggregation of platelets  Treat clients who have had cerebrovascular accidents or myocardial infarctions

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Antiplatelets Examples  Aspirin  Abciximab (ReoPro)  Clopidogrel bisulfate (Plavix)

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Thrombolytic Agents Action  Convert plasminogen to enzyme fibrinolysin; fibrinolysin dissolves clots Example  Streptokinase (IV) Caution  Hemorrhage